Boston & New England CRE News In Your Inbox.
Sign up for Connect emails to stay informed with CRE stories that are 150 words or less.
Verve Therapeutics Inks 105K-SF Life Science Lease in Fenway
Biotech firm Verve Therapeutics has signed a 10-year, 105,000-square-foot lease at 201 Brookline Ave. in the Fenway neighborhood of Boston.
The under-construction 201 Brookline will be a 14-story tower spanning approximately 500,000 square feet and is being developed by Samuels & Associates as well as Alexandria Real Estate Equities. Verve Therapeutics is focused on developing gene-editing medicine targeting cardiovascular disease. Verve’s lease includes up to $21M in tenant improvement funds and three months’ free rent, according to reports.
Other recent lease signings at the property include Kendall Square-based Tango Therapeutics for 65,000 square feet and venture capital firm Third Rock Ventures for 25,000 square feet.
- ◦Lease
- ◦Development